Harry completed his MSci in Biochemistry at the University of Bristol in 2021. Following his studies, Harry undertook a visiting researcher position in Dr Ingo Ringshausen’s lab in the haematology department at the University of Cambridge where he was investigating the role of lysosomes in the microenvironment of malignant B cell disease.

Harry is now a PhD student in the David lab, trying to understand what makes certain tissues more vulnerable to protein aggregation and how to promote resilience to protein aggregation with age.